Company Tongli Pharmaceuticals (USA), Inc.
Equities
TGLP
US89025Q1067
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Li Yao
CEO | Chief Executive Officer | 73 | 98-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Li Yao
CEO | Chief Executive Officer | 73 | 98-12-31 |
Zhi Jian Hao
BRD | Director/Board Member | 74 | 10-01-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,728,111 | 11,056,444 ( 75.07 %) | 0 | 75.07 % |
Company contact information
Tongli Pharmaceuticals (USA), Inc.
42-60 Main Street Apartment 6F
11355, Flushing
+
Sector
1st Jan change | Capi. | |
---|---|---|
+42.64% | 6.38B | |
-15.52% | 4.59B | |
+8.35% | 3.39B | |
-11.10% | 3.2B | |
-4.12% | 2.52B | |
+46.46% | 2B | |
-7.97% | 1.7B | |
-1.07% | 1.65B | |
-11.56% | 1.58B |